Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.6, replacing Revision: v3.6.5; this indicates a small update to the site framework without changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T18:17:39.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer revision updated to v3.6.5, representing a site update/version bump. No changes to the study details, eligibility criteria, or results are introduced.
    Difference
    0.1%
    Check dated 2026-08-10T13:24:04.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.6.4) indicating a recent update to the ClinicalTrials.gov record. No study details or terms appear to be changed in the visible context.
    Difference
    0.1%
    Check dated 2026-07-27T05:53:58.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates the page has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-07-05T14:34:41.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend or template update. This update does not modify the study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:45:34.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment heading; the old Intervention / Treatment label and the previous Revision note (Revision: v3.5.5) were removed, aligning with the new v3.6.0 revision.
    Difference
    0.5%
    Check dated 2026-06-13T18:05:52.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.